Sutro Biopharma (STRO) Treasury Shares (2017 - 2025)

Sutro Biopharma (STRO) has 9 years of Treasury Shares data on file, last reported at $417772.0 in Q4 2025.

• For the quarter ending Q4 2025, Treasury Shares fell 29.87% year-over-year to $417772.0; the trailing twelve-month figure through Dec 2025 stood at $417772.0 (down 29.87% YoY), and the FY2025 full-year result was $417772.0, down 29.87% from the prior year.
• Treasury Shares slipped to $417772.0 in Q4 2025, from $5.2 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $6.2 million in Q2 2025 to a low of $417772.0 in Q4 2025.
• A 5-year average of $4.0 million and a median of $3.9 million in 2022 frame the typical range for Treasury Shares.
• Across the five-year window, Treasury Shares surged 260.73% in 2021 and slumped 88.64% in 2024, its largest moves.
• Tracing STRO's Treasury Shares over 5 years: stood at $2.4 million in 2021, then soared by 64.67% to $4.0 million in 2022, then jumped by 32.5% to $5.2 million in 2023, then tumbled by 88.64% to $595691.0 in 2024, then slipped by 29.87% to $417772.0 in 2025.
• Business Quant data shows STRO's Treasury Shares at $417772.0 in Q4 2025, $5.2 million in Q3 2025, and $6.2 million in Q2 2025.